The role of new agents in advanced non—small–cell lung carcinoma
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology
Link
http://link.springer.com/content/pdf/10.1007/s11912-000-0014-z.pdf
Reference148 articles.
1. Rapp E, Pater JL, William A, et al.: Chemotherapy can prolong survival in patients with advanced non-small cell lung cancer. Report of a Canadian multi-center randomized trial. J Clin Oncol 1988, 6:633–641.
2. Cartei G, Cartei F, Cantone A, et al.: Cisplatin-cyclophosphamide-mitomycin combination chemotherapy with supportive care vs. supportive care alone for treatment of metastatic non-small cell lung cancer. J Natl Cancer Inst 1993, 85:794–800.
3. Cullen MA, Billinghaim LJ, Woodroffe CM, et al.: Mitomycin, ifosfamide, and cisplatin in unresectable non-small cell lung cancer; effects on survival and quality of life. J Clin Oncol 1999, 17:3188–3194. Chemotherapy (MIC) plus palliative care resulted in a significant improvement in median survival (6.9 months vs 4.8 months), with commensurate improvement in 1-year survival rates (28% vs 18%) in patients 75 years of age or under with advanced NSCLC and PS 0-2.
4. Non-Small Cell Lung Cancer Collaborative Group: Chemotherapy in non-small-cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Br Med J 1995, 311:899–909. This exhaustive meta-analysis demonstrated a 3-month improvement in median survival for chemotherapy plus best supportive care in NSCLC, compared with BSC alone. Overall, a 10% improvement in 1-year survival rate was noted.
5. Throngprasert S, Sanguanmitra P, Juthapan W, et al.: Relationship between quality of life and clinical outcomes in advanced non-small cell lung cancer: best supportive care versus BSC plus chemotherapy. Lung Cancer 1999, 24:17–21.
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Quantum‐Chemical Modeling of Cyclic Peptide‐Selenium Nanoparticle as an Anticancer Drug Nanocarrier;Bulletin of the Korean Chemical Society;2019-12-08
2. Structural and Electronic Properties of Cyclic Peptide-gold Nanoparticle as a Drug Delivery System;CHINESE J STRUC CHEM;2019
3. DFT study of SiO2 nanoparticles as a drug delivery system: structural and mechanistic aspects;Structural Chemistry;2018-11-15
4. The Structural Basis for the Allosteric Regulation of Ribonucleotide Reductase;Progress in Molecular Biology and Translational Science;2013
5. Targeting the Large Subunit of Human Ribonucleotide Reductase for Cancer Chemotherapy;Pharmaceuticals;2011-10-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3